ReviewFrontiers in endocrinology2025
Bridging east and west: integrative approaches to obesity management through traditional Chinese medicine.
Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of Potential Pancreatic Lipase Inhibitors from Traditional Chinese Medicines via Molecular Docking, Molecular Dynamics Simulation and In Vitro Validation.Current issues in molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study provides a comprehensive review of research pertaining to the treatment of obesity using traditional Chinese medicine (TCM). It encompasses fundamental theories, epidemiological data, pathological mechanisms, clinical practices, technological advancements, and directions for future research. In the section on fundamental theories, the etiology, pathogenesis, historical development, and theoretical foundations of obesity within TCM are examined. The current state of obesity has been analyzed through an epidemiological lens, along with the application of TCM and relevant clinical research findings. The pathological mechanism section evaluates the effect of TCM on metabolic regulation, inflammatory responses, and adipocyte functionality in the context of obesity. Clinical practices are illustrated through case studies of commonly utilized TCM prescriptions, acupuncture, moxibustion therapy, and integrative approaches combining traditional Chinese and Western medicine. The Technological Advancements section discusses the emergence of new formulations, modern diagnostic technologies, and personalized treatment strategies. The future outlook addresses potential research trajectories, prospects for integrating TCM with contemporary medical practices, and trends in international collaborations. Evidence suggests that TCM holds promise in various aspects of obesity treatment. However, further investigation is necessary to elucidate its efficacy and underlying mechanisms, enhance international cooperation and standardization efforts, and foster the advancement of TCM in obesity management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.